Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-03-13 00:00:00 ET · period of report 2024-03-11 · accession 0000950170-24-030932 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-03-13 | 2024-03-11 | TYRA | Bensen Daniel | COO | S - Sale | $20.00 | -200 | 431.7K | -0.0% | -$4,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | S | D | 200 | $20.00 | 431,683 | D | — | — |